Trending Now
Invesco QQQ Trust (QQQ) is on the recovery rally mode
Invesco QQQ Trust (QQQ) last traded at $280.97+1.92 (+0.69%). QQQ traded in the range of $276.17 - $281.21 with more than 44,802,936 shares...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Aligos Therapeutics ($ALGS): A Bold Move to Regain Nasdaq Compliance
Aligos Therapeutics, Inc. (ALGS), a clinical-stage biopharmaceutical company focusing on liver and viral diseases, recently executed a 1-for-25 reverse stock split. This...
MAKE IT MODERN
LATEST REVIEWS
Agios Pharmaceutical (NASDAQ:AGIO) Withdrawals European MAA For TIBSOVO® In Treating Refractory/Relapsed...
Agios Pharmaceutical Inc. (NASDAQ:AGIO) has withdrawn its European Marketing Authorization Application (MAA) for TIBSOVO® in treating refractory or relapsed acute myeloid leukemia patients with...
MAKE IT MODERN
PERFORMANCE TRAINING
Lyell Immunopharma Inc. (NASDAQ: LYEL) Announce FDA Approval of IND to Commence the first...
Lyell Immunopharma Inc. (NASDAQ: LYEL) has announced that the US FDA has approved an investigational new drug application to commence the first phase clinical...
Stocks in Focus (LXU, PIR, SFUN, TEDU, WKHS, GENE, CLUB)
Futures are red this morning right ahead of earning seasons which we start today with some financials.
Some...
Top Biotech Opportunities for the End-of-Year Run (CRSP, ATRX, PTPI, ALNA, MRNA, VRTX, IBB)
The Biotech space made a big move on Wednesday, sparking a rebirth in excitement about the space following the Federal Reserve's move...
Entasis Therapeutics Holdings Inc (NASDAQ: ETTX) and Zai Lab Ltd (NASDAQ: ZLAB) Complete Patient...
Entasis Therapeutics Holdings Inc (NASDAQ: ETTX) is a clinical-stage biopharma corporation that focuses primarily on developing and discovering novel antibacterial treatments. On the other hand, Zai...
Halozyme’s ENHANZE® (HALO) Technology Empowers OCREVUS ZUNOVO™: A New Era in MS Treatment
Subcutaneous Convenience, Uncompromised Efficacy
Halozyme Therapeutics (NASDAQ: HALO), a leader in innovative drug delivery solutions, recently announced a significant...
MAKE IT MODERN
